Pfizer Inc's Suppliers recorded an increase in sales by 11.82 % year on year in Q2 2026, sequentially sales grew by 9.63 %, Pfizer Inc recorded an increase in cost of sales by 8.31 % year on year, sequentially cost of sales grew by 15.33 % in Q2.
Pfizer Inc's Suppliers recorded an increase in sales by 11.82 % year on year in Q2 2026, sequentially sales grew by 9.63 %, Pfizer Inc recorded increase in cost of sales by 8.31 % year on year, sequentially cost of sales grew by 15.33 % in Q2.
Raw materials essential to our businesses are purchased worldwide in the ordinary
course of business from numerous suppliers. In general, these materials are available
from multiple sources. We have successfully secured the materials necessary to
meet our requirements where there have been short-term imbalances between supply
and demand, but generally at higher prices than those historically paid.
Pfizer Inc's Comment on Supply Chain
Raw materials essential to our businesses are purchased worldwide in the ordinary
course of business from numerous suppliers. In general, these materials are available
from multiple sources. We have successfully secured the materials necessary to
meet our requirements where there have been short-term imbalances between supply
and demand, but generally at higher prices than those historically paid.
PFE's Suppliers Net profit fell by
PFE's Suppliers Net margin fell in Q2 to
-1.76 %
8.46 %
PFE's Suppliers Net profit fell by -1.76 %
PFE's Suppliers Net margin fell in Q2 to 8.46 %
Pfizer Inc's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Pfizer Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Pfizer Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
4.42 %